Financial Services / Insurance - Property & Casualty

The Travelers Companies, Inc. (TRV)

$291.86
+1.01%
$62.1B
Market Cap
8.7
P/E Ratio
0.51
Beta
1.71%
Dividend Yield
Piotroski 4/9Altman Z 1.4 DistressROIC−WACC -3.1%

Quantitative Summary

Deterministic

At 8.7x earnings — a 55% discount to the sector average of 19.2x — TRV is in the lower valuation range. Financial health is average: Piotroski 4/9, Altman Z 1.4.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of The Travelers Companies, Inc. reveal a tension between robust accounting returns and inefficient capital deployment. While the DuPont decomposition highlights a high 19.1% ROE driven primarily by significant financial leverage (4.37x equity multiplier) rather than operational efficiency or margin expansion, this structure masks an underlying value destruction signal; the company's return on invested capital of 4.5% falls materially short of its cost of capital at 7.5%, resulting in a negative -3.0% spread that erodes intrinsic value over time. This inefficiency is compounded by weak financial health indicators, including a low Piotroski F-Score of 4/9 and an Altman Z-Score of 1.4, which collectively suggest elevated distress risk despite the current net margin of 12.9% supporting revenue growth of 5.2%.

Valuation metrics present a divergence between market pricing and historical or sector norms, with the stock trading at 10.7x P/E compared to an industry average of 18.4x. This discount implies that the market is heavily penalizing the negative ROIC-WACC spread and the associated distress risks rather than simply rewarding deep value. Although Fama-French factor analysis indicates a strong value tilt (HML: 0.694) and robust profitability characteristics (RMW: 0.112), these alpha signals may be insufficient to offset the fundamental drag of capital destruction, leaving the current price disconnected from the risks embedded in the leverage-heavy DuPont profile.

Recent insider activity adds a layer of caution, as $47,680,868 in net selling over the last 90 days suggests management may view the valuation or underlying fundamentals differently than outside investors. The combination of negative capital efficiency metrics, borderline solvency scores, and significant insider outflows creates a risk-reward profile where the apparent cheapness relative to sector peers is counterbalanced by structural weaknesses that could further depress returns if leverage constraints tighten or operational margins compress.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Valuation Context

8.7x
TRV P/E
19.2x
Sector Avg
34.4x
5Y Avg P/E
-55%
vs Sector

Currently trading 69% below its 5-year average P/E of 34.4x.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Technical Setup

AI Generated

The 50-day moving average of Travelers (TRV) has crossed above the 200-day moving average, suggesting a potential shift to an uptrend. The RSI at 54.8 indicates that near-term momentum is in positive territory but not yet overbought, hinting at continued strength if supported by other factors.

RSI (14)
SMA 50
SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
1.4
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

12.9%
Net Margin
4.5%
ROIC
7.6%
WACC
ROIC − WACC Spread: -3.1%— Negative spread.
+5.2%
Revenue Growth (YoY)
+25.8%
Earnings Growth (YoY)

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

12.9%
Net Profit Margin
NI ÷ Revenue
×
0.34x
Asset Turnover
Revenue ÷ Assets
×
4.37x
Equity Multiplier
Assets ÷ Equity
=
19.1%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

3.37x
Debt / Equity
19.3x
Interest Coverage
0.9x
Net Debt / EBITDA
8.9B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$48M
Net Selling
0
Buy Transactions
15
Sale Transactions
2026-02-26ROWLAND DAVID DONNAYSold 3/6 qtrsGrant$596,958
2026-02-26OLIVO MARIASold 3/6 qtrsGrant$1M
2026-02-26OLIVO MARIASold 3/6 qtrsSale$3M
2026-02-26ROWLAND DAVID DONNAYSold 3/6 qtrsSale$1M
2026-02-25MUNSON PAUL ESold 2/6 qtrsGrant$353,304

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.77
Act: $1.91
+147.7%
Q3
✓ Beat
Est: $3.61
Act: $6.51
+80.1%
Q2
✓ Beat
Est: $6.38
Act: $8.14
+27.6%
Q1
✓ Beat
Est: $8.80
Act: $11.13
+26.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Dividend History

$1.1000
Latest Dividend
$4.35
2025 Total
+4.8%
YoY Growth
9 yrs
Consecutive Increases
Annual Dividends per Share
$2.01
2016
$2.83
2017
$3.03
2018
$3.23
2019
$3.37
2020
$3.49
2021
$3.67
2022
$3.93
2023
$4.15
2024
$4.35
2025
$1.10
2026
DateAmountChange
2026-03-10$1.10000.0%
2025-12-10$1.10000.0%
2025-09-10$1.10000.0%
2025-06-10$1.1000+4.8%
2025-03-10$1.05000.0%
2024-12-10$1.05000.0%
2024-09-10$1.05000.0%
2024-06-10$1.0500+5.0%
2024-03-07$1.00000.0%
2023-12-07$1.00000.0%
2023-09-07$1.00000.0%
2023-06-08$1.0000+7.5%
Stock Splits
1998-05-12: 2:11994-06-07: 2:1

Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.

Risk Profile

21.1%
Annual Volatility
0.94
Sharpe (1Y)
-11.8%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

0.63
Market β
Mkt-RF
-0.237
Size (SMB)
Large-cap tilt
+0.694
Value (HML)
Value tilt
+0.112
Profit (RMW)
Robust
+0.215
Invest (CMA)
Conservative
Alpha (annual): +2.58%
R²: 28.6%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

10.2
Forward P/E
2.36
PEG Ratio
1.94
Price/Book
1M
Avg Volume
$313.12
52W High
$249.19
52W Low
67%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$9.6B
Tracked Passive Exposure
8
ETFs Holding TRV
0.15%
Avg Weight in ETFs
$6.2T
Total ETF AUM

When investors buy or sell ETFs like DIA or KIE, the fund manager is mechanically forced to buy or sell TRV shares regardless of The Travelers Companies, Inc.'s individual fundamentals. We estimate $9.6B of passive capital is structurally linked to TRV through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in The Travelers Companies, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

TRV Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TRVEpicenterVTIETFVOOETFIVVETFGSHigh RiskJPMHigh RiskBRK.BUnknownVLow RiskCATLow Risk
TRV Price Drop (%)0

If The Travelers Companies, Inc. (TRV) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies GOLDMAN SACHS GROUP INC (GS) as the most exposed collateral stock, sharing 2 ETFs with TRV. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 34 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TRV Ownership Dynamics

Passive funds hold 1 in every 6 TRV shares, reducing daily market volatility.

Ticker
TRV
Total Shares
213M
ETF Lock-Up
15.5%
Display Mode
Total Float Impact
15.5%Locked Float

The Travelers Companies, Inc. (TRV) exerts notable gravity on the passive index market, currently representing 3.8% of the DIA (DIA) and 1.8% of the KIE (KIE). Across 34 tracked ETFs, approximately 33M shares (15.5% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.

Float lock-up computed from 34 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TRV Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
TRV
PRICE
$291.86
FLOOR (POC)
$267.65
STRENGTH
Medium
$248$251$255$258$2617%$2646%$268POC 8%$2717%$274$278$281$2847%$287$2916%$291.86$294$2976%$3007%$3046%$307$310
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for The Travelers Companies, Inc. over the past year sits near $267.65 (8% of 252-day volume). The current price of $291.86 trades 9.0% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-061,209$301.35$364,332.15
2026-04-297,937$310.02$2.5M
2026-04-2712,795$302.73$3.9M
2026-04-23104$301.68$31,374.72
2026-04-211,757$300.78$528,470.46
2026-04-20162$300.81$48,731.22
2026-04-17395$298.84$118,041.8
2026-04-099$301.59$2,714.31
2026-04-074$295.55$1,182.2
2026-04-064$293.99$1,175.96
2026-03-256,538$293.01$1.9M
2026-03-1332$302.01$9,664.32
2026-03-0693$306.64$28,517.52
2026-03-041,919$310.97$596,751.43
2026-03-03100$310.67$31,067
2026-03-02100$308.64$30,864
2026-02-23100$304.93$30,493
2026-02-1125,328$298.61$7.6M
2026-02-102$292.82$585.64
2026-02-03451$285.63$128,819.13
2026-01-23619$278.48$172,379.12
2026-01-125$281.96$1,409.8
2025-12-19892$293.65$261,935.8
2025-12-1019,544$279.16$5.5M
2025-12-0922,714$279.87$6.4M
2025-12-086,827$280.89$1.9M
2025-12-0135$292.86$10,250.1
2025-11-2484$290.07$24,365.88
2025-11-1846$284.51$13,087.46
2025-11-133$286.13$858.39

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
HIG0.8530.813High co-movement
L0.7370.708High co-movement
CINF0.7170.619High co-movement
CB0.7160.674High co-movement
ACGL0.7140.745High co-movement
ALL0.6980.698Moderate
WRB0.6940.628Moderate
AFL0.6760.670Moderate
MMC0.6020.516Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare TRV to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.